CDKN2A and acute lymphoblastic leukemia: found that the FBXW7 mutation, CDKN2A/B deletion, and STIL-TAL1 fusion were only present in ETP-ALL, and these mutations could be used to differentiate ETP-ALL and mixed phenotype acute leukemia with the T/myeloid phenotype (19).